|Day's Range||1.4692 - 1.4710|
|52 Week Range||1.2877 - 1.4937|
BOSTON, May 05, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2022 and reiterated full year 2022 product revenue guidance.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) insiders who bought shares over the past year were rewarded...